WLLW — Willow Biosciences Balance Sheet
0.000.00%
Last trade - 00:00
- CA$11.45m
- CA$10.44m
- CA$1.17m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 19.7 | 15.9 | 30.1 | 15 | 3.17 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.654 | 0.289 | 0.089 | 0.282 | 0.166 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 20.8 | 17 | 31.3 | 16.2 | 4.17 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.66 | 4.74 | 3.65 | 1.92 | 2.44 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 33.9 | 21.9 | 35 | 18.1 | 6.67 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.85 | 1.56 | 1.41 | 1.72 | 1.81 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.9 | 22.4 | 5.33 | 1.77 | 3.24 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 22 | -0.559 | 29.7 | 16.4 | 3.44 |
Total Liabilities & Shareholders' Equity | 33.9 | 21.9 | 35 | 18.1 | 6.67 |
Total Common Shares Outstanding |